Unrecognized side effect of statin treatment: unilateral blepharoptosis.
A 43-year-old man receiving statin monotherapy (10 mg atorvastatin) for hypercholesterolemia had unilateral blepharoptosis as the result of isolated myositis of the levator muscle. Statin-induced myositis in the levator muscle should be considered in the differential diagnosis of acquired unilateral blepharoptosis of unknown cause.
Ertas
Fatih Sinan
FS
Ankara University, School of Medicine, Department of Cardiology, Turkey.
Ertaş
Nilgün Markal
NM
Gulec
Sadi
S
Atmaca
Yusuf
Y
Tanju
Sumru
S
Sener
Cumhur
C
Erol
Cetin
C
D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D001763:Blepharoptosis / Q000139:chemically induced* / Q000175:diagnosis; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D009220:Myositis / Q000139:chemically induced / Q000175:diagnosis; D009801:Oculomotor Muscles / Q000187:drug effects / Q000473:pathology; D011758:Pyrroles / Q000009:adverse effects*
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin